Interferon-γ-inducing factor gene transfection into Lewis lung carcinoma cells reduces tumorigenicity in vivo

Japanese Journal of Cancer Research

Volumn 88, Issue 5, 1997, Pages 501-505

  Fukumoto, Hisao ^a   Nishio, Makoto ^c   Nishio, Kazuto ^a   Heike, Yuji ^a   Arioka, Hitoshi ^a   Kurokawa, Hirokazu ^a   Ishida, Tomoyuki ^a   Fukuoka, Kazuya ^a   Nomoto, Taisuke ^a   Ohe, Yuichiro ^b   Saijo, Nagahiro ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

Interferon ; Interleukin 12; Lewis lung carcinoma; Murine interferon inducing factor; Transfectant

Indexed keywords

CD3 ANTIGEN; COMPLEMENTARY DNA; GAMMA INTERFERON; INTERFERON INDUCING AGENT; INTERLEUKIN 12; RECOMBINANT INTERLEUKIN 12;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOLOGY; CANCER IMMUNOTHERAPY; CANCER TRANSPLANTATION; CARCINOGENICITY; CONTROLLED STUDY; CULTURE MEDIUM; EXPRESSION VECTOR; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSFECTION; IMMUNOREGULATION; IN VITRO STUDY; INTERFERON PRODUCTION; INTRAPERITONEAL DRUG ADMINISTRATION; LEWIS CARCINOMA; LUNG CARCINOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 15144339968     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1997.tb00409.x     Document Type: Article

References (13)

1. Bliss, J., van Cleave, V., Murray, K., Wiencis, A., Ketchum, M., Maylor, R., Haire, T., Resmini, C., Abbas, A. K. and Wolf, S. F. IL-12, as an adjuvant, promotes a T helper 1 cell, but does not suppress a T helper 2 cell recall response. J. Immunol., 156, 887-894 (1996).
2. Trinchieri, G. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood, 84, 4008-4027 (1994).
3. Zou, J. P., Yamamoto, N., Fujii, T., Takenaka, H., Kobayashi, M., Herrmann, S. H., Wolf, S. F., Fujiwara, H. and Hamaoka, T. Systemic administration of rIL-12 induces complete tumor regression and protective immunity: response is correlated with a striking reversal of suppressed IFN-gamma production by anti-tumor T cells. Int. Immunol., 7, 1135-1145 (1995).
4. Okamura, H., Tsutsi, H., Komatsu, T., Yutsudo, M., Hakura, A., Tanimoto, T., Torigoe, K., Okura, T., Nukada, Y., Hattori, K., Arita, K., Namba, M., Tanabe, F., Konishi, K., Fukuda. S. and Kurimoto, M. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature, 378, 88-91 (1995).
5. Okamura, H., Nagata, K., Komatsu, T., Tanimoto, T., Nukata, Y., Tanabe, F., Akita, K., Torigoe, K., Okura, T., Fukuda, S., Kurimoto, M. A novel costimulatory factor for gamma interferon induction found in the livers of mice causes endotoxic shock. Infect. Immun., 63, 3966-3972 (1995).
6. Nakamura, K., Okamura, H., Nagata, K., Komatsu, T. and Tamura, T. Purification of a factor which provides a costimulatory signal for γ interferon production. Infect. Immun., 61, 64-70 (1993).
7. Sugiura, K. and Stock, C. C. Studies in a tumor spectrum. III. The effect of phosphoramides on the growth of a variety of mouse and rat. Cancer Res., 15, 38-51 (1955).
8. Merriman, R. L., Shackelford, K. A., Tanzer, L. R., Campbell, J. B., Bemis, K. G. and Matsumoto, K. Drug treatments for metastasis of the Lewis lung carcinoma: lack of correlation between inhibition of lung metastasis and survival. Cancer Res., 49, 4509-4516 (1989).
9. Karasuyama, H. and Melchers, F. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur. J. Immunol., 18, 97-104 (1988).
10. Feigner, P. L., Gadek, T. R., Holm, M., Roman, R., Chan, H. W., Wenz, M., Northrop, J. P., Ringold, G. M. and Danielsen, M. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA, 84, 7413-7417 (1987).
11. Ohe, Y., Podack, E. R., Olsen, K. J., Miyahara, Y., Ohira, T., Miura, K., Nishio, K. and Saijo, N. Combination effect of vaccination with IL2 and IL4 cDNA transfected cells on the induction of a therapeutic immune response against Lewis lung carcinoma cells. Int. J. Cancer, 53, 432-437 (1993).
12. Cohen, J. IL-12 deaths: explanation and a puzzle. Science, 270, 908 (1995).
13. Vagliani, M., Rodolfo, M., Cavallo, F., Parenza, M., Melani, C., Parmiani, G., Forni, G. and Colombo, M. P. Interleukin 12 potentiates the curative effect of a vaccine based on interleukin 2-transduced tumor cells. Cancer Res., 56, 467-470 (1996).